221 related articles for article (PubMed ID: 25091389)
1. The clinical value of dynamic contrast-enhanced magnetic resonance imaging at 3.0T to detect prostate cancer.
Zhang X; Quan X; Lu S; Huang F; Yang J; Chan Q; Lin T
J Int Med Res; 2014 Oct; 42(5):1077-84. PubMed ID: 25091389
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
5. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
7. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
9. [Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].
Baccos A; Schiavina R; Zukerman Z; Busato F; Gaudiano C; Salizzoni E; Fiorentino M; Golfieri R; Martorana G
Urologia; 2012; 79(2):116-22. PubMed ID: 22522463
[TBL] [Abstract][Full Text] [Related]
10. Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
Wu LM; Xu JR; Gu HY; Hua J; Zhu J; Chen J; Zhang W; Hu J
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):252-64. PubMed ID: 23313568
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
[TBL] [Abstract][Full Text] [Related]
12. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
[TBL] [Abstract][Full Text] [Related]
13. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
